INDUCTION OF HOST IMMUNE RESPONSES USING SALMONELLAVECTORED VACCINES

4th Edition: Virulence Mechanisms of Bacterial Pathogens

Volumn , Issue , 2022, Pages 297-313

  Curtiss, Roy ^a,b   Zhang, Xin ^a,b   Wanda, Soo Young ^a,b   Kang, Ho Young ^a,b   Konjufca, Vjollca ^a,b   Li, Yuhua ^a,b   Gunn, Bronwyn ^a,b   Wang, Shifeng ^a,b   Scarpellini, Giorgio ^a,b   Lee, In Soo ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85151199006     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815851.ch20     Document Type: Chapter

References (62)

1. Baud, D., J. Benyacoub, V. Revaz, M. Kok, F. Ponci, M. Bobst, R. Curtiss III, P. De Grandi, and D. Nardelli-Haefliger. 2004. Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium. Infect. Immun. 72:750-756.
2. Bauman, N., and B. D. Davis. 1957. Selection of auxotrophic bacterial mutants through diaminopimelic acid or thymine deprival. Science 126:170.
3. Bienenstock, J., M. McDermott, D. Befus, and M. O’Neill. 1978. A common mucosal immunologic system involving the bronchus, breast and bowel. Adv. Exp. Med. Biol. 107:53-59.
4. Black, S., and N. G. Wright. 1955. Aspartic beta-semialdehyde dehydrogenase and aspartic beta-semialdehyde. J. Biol. Chem. 213:39-50.
5. Briles, D. E., R. C. Tart, E. Swiatlo, J. P. Dillard, P. Smith, K. A. Benton, B. A. Ralph, A. Brooks-Walter, M. J. Crain, S. K. Hollingshead, and L. S. McDaniel. 1998. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:645-657.
6. Briles, D. E., S. Hollingshead, A. Brooks-Walter, G. S. Nabors, L. Ferguson, M. Schilling, S. Gravenstein, P. Braun, J. King, and A. Swift. 2000. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 18:1707-1711.
7. Briles, D. E., J. Yother, and L. S. McDaniel. 1988. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev. Infect. Dis. 10(Suppl. 2):S372-S374.
8. Carter, P. B., and F. M. Collins. 1974. The route of enteric infection in normal mice. J. Exp. Med. 139:1189-1203.
9. Cebra, J. J., P. J. Gearhart, R. Kamat, S. M. Robertson, and J. Tseng. 1977. Origin and differentiation of lymphocytes involved in the secretory IgA responses. Cold Spring Harbor Symp. Quant. Biol. 41:201-215.
10. Centers for Disease Control and Prevention. 2005. Salmonella. Surveillance: Annual Summary, 2004. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
11. Chapman, H. D., B. Roberts, M. W. Shirley, and R. B. Williams. 2005. Guidelines for evaluating the efficacy and safety of live anticoccidial vaccines, and obtaining approval for their use in chickens and turkeys. Avian Pathol. 34:279-290.
12. Charbit, A., S. M. Newton, P. E. Klebba, J. M. Clement, C. Fayolle, R. Lo-Man, C. Leclerc, and M. Hofnung. 1997. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development. Behring Inst. Mitt. 98:135-142.
13. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
14. Chen, L. M., G. Briones, R. O. Donis, and J. E. Galan. 2006. Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect. Immun. 74:5826-5833.
15. Collins, L. V., S. Attridge, and J. Hackett. 1991. Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect. Immun. 59:1079-1085.
16. Collins, L. V., and J. Hackett. 1991. Sequence of the phosphomannose isomerase-encoding gene of Salmonella typhimurium. Gene 103:135-136.
17. Curtiss, R., III. 2002. Bacterial infectious disease control by vaccine development. J. Clin. Investig. 110:1061-1066.
18. Curtiss, R., III. 2005. Antigen delivery systems: development of live recombinant attenuated bacterial antigen and DNA vaccine delivery vector vaccines, p. 1009-1037. In J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer (ed.), Mucosal Immunology, 3rd ed., vol. 1. Academic Press, San Diego, CA.
19. Curtiss, R., III, T. Doggett, A. Nayak, and J. Srinivasan. 1996. Strategies for the use of live recombinant avirulent bacterial vaccines for mucosal immunization, p. 499-511. In H. Kiyono and M. F. Kagnoff(ed.), Essentials of Mucosal Immunology. Academic Press, San Diego, CA.
20. Dalloul, R. A., and H. S. Lillehoj. 2005. Recent advances in immunomodulation and vaccination strategies against coccidiosis. Avian Dis. 49:1-8.
21. Earhart, C. F. 1996. Uptake and metabolism of iron and molybdenum, p. 1075-1090. In F. C. Neidhardt et al. (ed.), Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd ed., vol. 1. ASM Press, Washington, DC.
22. Evans, D. T., L. M. Chen, J. Gillis, K. C. Lin, B. Harty, G. P. Mazzara, R. O. Donis, K. G. Mansfield, J. D. Lifson, R. C. Desrosiers, J. E. Galan, and R. P. Johnson. 2003. Mucosal priming of simian immunodeficiency virusspecific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol. 77:2400-2409.
23. Formal, S. B., L. S. Baron, D. J. Kopecko, O. Washington, C. Powell, and C. A. Life. 1981. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect. Immun. 34:746-750.
24. Fu, Y., and J. E. Galan. 1998. Identification of a specific chaperone for SptP, a substrate of the centisome 63 type III secretion system of Salmonella typhimurium. J. Bacteriol. 180:3393-3399.
25. Fu, Y., and J. E. Galan. 1998. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol. Microbiol. 27:359-368.
26. Gaines, S., H. Sprinz, J. G. Tully, and W. D. Tigertt. 1968. Studies on infection and immunity in experimental typhoid fever. VII. The distribution of Salmonella typhi in chimpanzee tissue following oral challenge, and the relationship between the numbers of bacilli and morphologic lesions. J. Infect. Dis. 118:293-306.
27. Galan, J. E., and R. Curtiss III. 1989. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc. Natl. Acad. Sci. USA 86:6383-6387.
28. Galen, J. E., J. Nair, J. Y. Wang, S. S. Wasserman, M. K. Tanner, M. B. Sztein, and M. M. Levine. 1999. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun. 67:6424-6433.
29. Gentschev, I., I. Glaser, W. Goebel, D. J. McKeever, A. Musoke, and V. T. Heussler. 1998. Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infect. Immun. 66:2060-2064.
30. Gentschev, I., H. Mollenkopf, Z. Sokolovic, J. Hess, S. H. Kaufmann, and W. Goebel. 1996. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene 179:133-140.
31. Gerdes, K., A. P. Gultyaev, T. Franch, K. Pedersen, and N. D. Mikkelsen. 1997. Antisense RNA-regulated programmed cell death. Annu. Rev. Genet. 31:1-31.
32. Guzman, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121-4130.
33. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103.
34. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
35. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA 92:2904-2908.
36. Hollingshead, S. K., R. Becker, and D. E. Briles. 2000. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68:5889-5900.
37. Kang, H. Y., and R. Curtiss III. 2003. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol. Med. Microbiol. 37:99-104.
38. Kang, H. Y., J. Srinivasan, and R. Curtiss III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
39. Konjufca, V., S. Y. Wanda, M. C. Jenkins, and R. Curtiss III. 2006. A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect. Immun. 74:6785-6796.
40. Koshland, D., and D. Botstein. 1980. Secretion of β-lactamase requires the carboxy end of the protein. Cell 20:749-760.
41. Kotton, C. N., A. J. Lankowski, N. Scott, D. Sisul, L. M. Chen, K. Raschke, G. Borders, M. Boaz, A. Spentzou, J. E. Galan, and E. L. Hohmann. 2006. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella type III secretion system. Vaccine 24:6216-6224.
42. Kubori, T., and J. E. Galan. 2003. Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115:333-342.
43. Makela, P. H., and B. A. Stocker. 1969. Genetics of polysaccharide biosynthesis. Annu. Rev. Genet. 3:291-322.
44. McDaniel, L. S., J. Yother, M. Vijayakumar, L. McGarry, W. R. Guild, and D. E. Briles. 1987. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J. Exp. Med. 165:381-394.
45. McDougald, L. R. 2003. Coccidiosis. In Y. M. Saif (ed.), Diseases of Poultry, 11th ed. Iowa State Press, Ames, IA.
46. Minor, L. 1984. Salmonella, p. 427-458. In R. E. Buchanan and N. E. Gibbons (ed.), Bergey’s Manual of Systematic Bacteriology, 8th ed. Williams and Wilkins, Baltimore, MD.
47. + expressioncloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693-697.
48. Nayak, A. R., S. A. Tinge, R. C. Tart, L. S. McDaniel, D. E. Briles, and R. Curtiss III. 1998. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against. Streptococcus pneumoniae. Infect. Immun. 66:3744-3751.
49. Orr, N., J. E. Galen, and M. M. Levine. 2001. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA. Vaccine 19:1694-1700.
50. Pogonka, T., C. Klotz, F. Kovacs, and R. Lucius. 2003. A single dose of recombinant Salmonella typhimurium induces specific humoral immune responses against heterologous Eimeria tenella antigens in chicken. Int. J. Parasitol. 33:81-88.
51. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
52. Roberts, M., S. M. Chatfield, and G. Dougan. 1994. Salmonella as carriers of heterologous antigens. In D. T. O’Hagan (ed.), Novel Delivery Systems for Oral Vaccines. CRC Press, Inc., New York, NY.
53. Rüssmann, H., H. Shams, F. Poblete, Y. Fu, J. E. Galan, and R. Q. Donis. 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281:565-568.
54. Samatey, F. A., K. Imada, S. Nagashima, F. Vonderviszt, T. Kumasaka, M. Yamamoto, and K. Namba. 2001. Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling. Nature 410:331-337.
55. Schodel, F., and R. Curtiss III. 1995. Salmonellae as oral vaccine carriers. Dev. Biol. Stand. 84:245-253.
56. Smith, K. D., E. Andersen-Nissen, F. Hayashi, K. Strobe, M. A. Bergman, S. L. Barrett, B. T. Cookson, and A. Aderem. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4:1247-1253.
57. Summers, R. G., and J. R. Knowles. 1989. Illicit secretion of a cytoplasmic protein into the periplasm of Escherichia coli requires a signal peptide plus a portion of the cognate secreted protein. Demarcation of the critical region of the mature protein. J. Biol. Chem. 264:20074-20081.
58. Vermeulen, A. N. 2004. Avian coccidiosis: a disturbed host-parasite relationship to be restored. Symp. Soc. Exp. Biol. 2004:211-241, 243-245.
59. Weisz-Carrington, P., M. E. Roux, M. McWilliams, J. M. Phillips-Quagliata, and M. E. Lamm. 1979. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. J. Immunol. 123:1705-1708.
60. Williams, R. B. 1998. Epidemiological aspects of the use of live anticoccidial vaccines for chickens. Int. J. Parasitol. 28:1089-1098.
61. Yonekura, K., S. Maki-Yonekura, and K. Namba. 2003. Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy. Nature 424:643-650.
62. Yother, J., and D. E. Briles. 1992. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174:601-609.